Ex-vivo stimulation of tumor-infiltrating CD4+ and CD8+ memory T-cells (PMA/Ionomycin) revealed a prominent shift from a Th2 towards a Th1 phenotype with an increased intracellular ratio of IFN-γ to IL-4. The gene discussed is IFNG; the disease is neoplasm.